Targeting mitotic kinesin KIF20A: A differentiation-based therapeutic strategy for glioblastoma stem/progenitor cells
Stem Cell Reports · 2026
DOI: 10.1016/j.stemcr.2026.103013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cell Reports, 2026. Verfasst von Runxiang Qiu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stem Cell Biology and Regenerative Medicine, Beckman Research Institute of the City of Hope, Duarte, CA 91010, USA. Hauptthemen laut MEDLINE: Kinesins, Glioblastoma, Neoplastic Stem Cells, Cell Differentiation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Glioblastoma multiforme (GBM) remains refractory to current treatment modalities. Differentiation-based approaches, which force cancer stem/progenitor cells to exit the cell cycle and adopt terminal fates, offer an alternative therapeutic strategy. Cell fate regulators operating during stem/progenitor cell divisions integrate proliferative and anti-proliferative cues and represent particularly attractive points of intervention. Here, we investigated the therapeutic potential of targeting mitotic kinesin KIF20A in GBM stem/progenitor cells. KIF20A is a crucial component of cytokinetic machinery and cooperates with a network of cell fate regulators to balance proliferative and differentiative divisions in neural stem/progenitor cells (NSPCs). Using complementary in vitro and in vivo models, including 2D cultures, 3D organoids, and intracranial xenografts, we show that inhibition of KIF20A drives cell cycle exit and induces a postmitotic/differentiated state in GBM stem/progenitor cells, resulting in a marked suppression of proliferation. Together, these findings establish KIF20A as a key vulnerability in GBM and a promising target for differentiation-based intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Stem Cell Biology and Regenerative Medicine, Beckman Research Institute of the City of Hope, Duarte, CA 91010, USA.
- Division of Comparative Medicine, Beckman Research Institute of the City of Hope, Duarte, CA 91010, USA.
- Department of Hematology and Hematopoietic Cell Transplantation, T Cell Therapeutics Research Laboratories, Beckman Research Institute of the City of Hope, Duarte, CA 91010, USA.
- Department of Diabetes & Cancer Metabolism, Beckman Research Institute of the City of Hope, Duarte, CA 91010, USA.
- Department of Radiation Oncology, Beckman Research Institute of the City of Hope, Duarte, CA 91010, USA.
- Department of Stem Cell Biology and Regenerative Medicine, Beckman Research Institute of the City of Hope, Duarte, CA 91010, USA. Electronic address: mbarish@coh.org.
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Qiu, R., Ojeda, A. V., Gonzalez, C., Abatay, V., Wu, J., Awabdeh, D., Starr, R., Carlesso, N., Shuck, S., Li, Y. R., Brown, C. E., Barish, M. E., & Lu, Q. (2026). Targeting mitotic kinesin KIF20A: A differentiation-based therapeutic strategy for glioblastoma stem/progenitor cells. Stem Cell Reports. https://doi.org/10.1016/j.stemcr.2026.103013
Vancouver
Qiu R, Ojeda AV, Gonzalez C, Abatay V, Wu J, Awabdeh D, et al. Targeting mitotic kinesin KIF20A: A differentiation-based therapeutic strategy for glioblastoma stem/progenitor cells. Stem Cell Reports. 2026. doi:10.1016/j.stemcr.2026.103013
BibTeX
@article{Qiu2026,
author = {Qiu, Runxiang and Ojeda, Alejandra Velazquez and Gonzalez, Cesar and Abatay, Vincente and Wu, Jun and Awabdeh, Dina and Starr, Renate and Carlesso, Nadia and Shuck, Sarah and Li, Yun Rose and Brown, Christine E and Barish, Michael E and Lu, Qiang},
title = {Targeting mitotic kinesin KIF20A: A differentiation-based therapeutic strategy for glioblastoma stem/progenitor cells},
journal = {Stem Cell Reports},
year = {2026},
doi = {10.1016/j.stemcr.2026.103013}
}
EUVIMED